In the comprehensive study of the global cell-free DNA isolation and extraction market, Our Research Team extensively covers the following:

• Market numbers on micro-segments influencing the market
• Market share analysis of key market players
• Growth share analysis of companies
• Impact of COVID-19 on the global cell-free DNA isolation and extraction market
• Growth analysis by consumables, technology, techniques, application, end-user, and region
• Detailed company and product profiling for 15 companies and snapshot for ten companies

Besides these parameters, the study also encompasses the market growth drivers, market restraining factors, opportunities, competition mapping, and segmental analysis.

Our Research Team study indicates that the growing prevalence of cancer, strategic initiatives by key market players, and rise in microbial sequencing are the major factors anticipated to contribute to the growth of the global cell-free DNA isolation and extraction market.

Our Research Team study highlights the following in the report:

• Emerging opportunities in cell-free DNA isolation and extraction market
• Impact of COVID-19 on the global cell-free DNA isolation and extraction market
• Market scenario for cell-free DNA isolation and extraction kits, tubes, and consumables
• Drivers promoting the growth of the market

Data from different segments of the market has been analyzed minutely to gain a holistic view of the market. These segments include market segmented based on consumables, platform, techniques, application, end-user, and region. Each of these segments is further categorized into sub-segments and micro-segments to compile an in-depth study.

Key insights are drawn from in-depth interviews with the key opinion leaders of 25 leading companies, market participants, and vendors. Key players operating in the global cell-free DNA isolation and extraction market include Thermo Fisher Scientific Inc., QIAGEN, Danaher, PerkinElmer, Inc., Endress+Hauser AG, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, Illumina, Inc., Takara Bio Inc., Aline Biosciences, EpiGentek Group, Inc., Omega Bio-tek, Inc., Promega Corporation, Streck, Inc., AccuBioMed Co., Ltd., AMSBIO, Covaris, Inc., EntroGen, Inc., NeoGeneStar LLC, Norgen Biotek Corp., STRATEC SE, System Biosciences, LLC, and Vela Diagnostics

Who should buy this report?

• Manufacturers of cell-free DNA isolation and extraction kits, tubes, and other consumables
• Pharmaceutical and biotechnology companies
• Research and academic institutions

Insightful Questions Covered to Enable Companies Take Strategic Decisions

• How is cell-free DNA isolation and extraction revolutionizing oncology?
• What are the major market drivers, challenges, and opportunities in the global cell-free DNA isolation and extraction market?
• What are the underlying structures resulting in the emerging trends within the global cell-free DNA isolation and extraction market?
• How is the COVID-19 pandemic impacting the global cell-free DNA isolation and extraction ecosystem?
• What are the key development strategies that the major players are implementing in order to sustain themselves in the competitive market?
• What are the key regulatory implications in developed and developing regions pertaining to the use of cell-free DNA isolation and extraction-targeted therapies?
• What are the potential entry barriers expected to be faced by the companies willing to enter a particular region?
• How is each market segment expected to grow during the forecast period 2021-2031, and what is the anticipated revenue to be generated by each segment? Following are the segments:
o Consumable (Cell-Free DNA Isolation and Extraction Kits, Cell-Free DNA Isolation and Extraction Tubes, and Other Consumables)
o Platform (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), and Other Platforms)
o Technique (Magnetic Beads-Based, Spin Column-Based, and Other Techniques)
o Application (Non-Invasive Prenatal Testing (NIPT), Oncology, Transplant Rejection, and Other Applications)
o End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Contract Research Organizations (CROs), and Other End Users)
o Region (North America, Europe, Asia-Pacific, and Rest-of-the-World)
• What are the growth opportunities for the cell-free DNA isolation and extraction companies in the region of their operation?
• Who are the leading players with significant offerings in the global cell-free DNA isolation and extraction market?
• Which companies are anticipated to be highly disruptive in the future, and why?
Buy the report: Cell-Free DNA Isolation and Extraction Market – A Global and Regional Analysis: Focus on Consumables, Platform, Techniques, Application, End User, and Region – Analysis and Forecast, 2021-2031
[contact-form-7]

The post CRI Report: cell-free DNA isolation and extraction market to reach $735.1 million by 2031 first appeared on CRI Report.